Rising sales of Pfizer Inc.'s key new medicines and prospects that more drugs will be approved soon have analysts speculating the biggest U.S. drugmaker won't break up after all.
Local News from NorthJersey.com, The Record
Tue, 08/02/2016 - 11:13am
Rising sales of Pfizer Inc.'s key new medicines and prospects that more drugs will be approved soon have analysts speculating the biggest U.S. drugmaker won't break up after all.